UNSPSC 51352401: Ethinyl estradiol/ferrous fumarate/norethindrone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class HS200. This VA Drug Class (HS200) classifies this compound as belonging to the group CONTRACEPTIVES, SYSTEMIC.

UNSPSC 51352401 Ethinyl estradiol/ferrous fumarate/norethindrone, a Commodity code, covers branded and generic oral contraceptive combinations that state and local governments procure primarily through pharmacy benefit programs, cooperative purchasing alliances, and direct-to-manufacturer channels to supply Medicaid populations, employee health plans, and public health clinics. State and local buyers under this code include health and human services agencies, multistate cooperative purchasing organizations, and their constituent member jurisdictions — state departments, counties, and municipalities that operate or contract for pharmacy benefit services.

The code shows recent activity concentrated in the Upper Midwest and Southwest. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities including Oregon; vendors must supply through three authorized wholesalers and comply with cGMP and Drug Supply Chain Security Act certifications. The Texas Health and Human Services Commission issued a Request for Information in April 2026 to gather vendor capabilities and market intelligence regarding a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking to establish direct relationships between the state's pharmacy benefit program and pharmaceutical manufacturers outside existing pharmacy benefit manager and group purchasing organization arrangements. Both solicitations emphasize pricing flexibility, compliance with federal drug-supply standards, and capability to service state employee and Medicaid populations across multiple jurisdictions through established wholesaler networks or direct manufacturer channels.